Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-06-28 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于使用闲置募集资金委托理财到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company Yifeng Pharmacy Chain Co., Ltd. regarding the redemption of entrusted financial management funds using idle raised funds. It details the amount redeemed, the product involved (a structured deposit), dates, and the company's board approval process. The document is short (1258 characters) and focuses on a specific financing activity related to the use of raised funds, not a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or management report. It is an update on capital usage and financing activities, specifically about entrusted financial management and redemption of structured deposits. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-06-28 Chinese
益丰药房关于限制性股票回购注销实施完成暨不调整可转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 益丰大药房连锁股份有限公司 regarding the completion of repurchase and cancellation of restricted stocks and the resulting decision not to adjust the convertible bond's conversion price. It includes detailed explanations of the repurchase, cancellation, and the formulas used to calculate the conversion price adjustment, concluding that the conversion price remains unchanged. The document is a specific corporate announcement about capital structure changes related to convertible bonds and stock repurchase, not a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion but focuses on capital/financing updates related to convertible bonds and stock repurchase. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 2316 characters, which is consistent with an announcement rather than a full report.
2024-06-26 Chinese
益丰药房2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2024 second extraordinary shareholders' meeting of Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, attendance, voting results on various proposals including director and supervisor elections, and legal witness statements confirming the legality of the meeting and voting process. There is no financial data or report content, but rather the official announcement of voting results from a shareholders' meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2024-06-25 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2024年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of the 2024 second extraordinary general meeting (临时股东大会) of the company. It details the legality and compliance of the meeting process under relevant laws and company regulations. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of voting results but a legal opinion on the meeting's procedural validity. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural filing related to a shareholder meeting but not the meeting materials themselves or voting results announcement.
2024-06-25 Chinese
益丰药房第五届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the company Yifeng Pharmacy Chain Co., Ltd. regarding the resolutions passed at the first meeting of the fifth board of directors. It details the election of the board chairman, appointment of board committees, and hiring of senior management personnel. The document includes voting results and personal resumes of the appointed directors and executives. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management changes, which fits the category of Board/Management Information (MANG). The document length is 4461 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is MANG with high confidence.
2024-06-25 Chinese
益丰药房第五届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolution from the first meeting of the fifth Supervisory Board of Yifeng Pharmacy Chain Co., Ltd. It includes details about the meeting attendance, voting results, and election of the Supervisory Board chairman. There is no financial data, audit information, or report content. It is a formal announcement related to board/management changes, specifically the election of a new Supervisory Board chairman. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a notice of report publication, so it is not RPA or RNS.
2024-06-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.